INTERNATIONAL PATENT: INSTITUT STRAUMANN AG FILES APPLICATION FOR "INJECTABLE COMPOSITIONS COMPRISING ENAMEL MATRIX DERIVATIVE (EMD) PROTEINS AND HUMAN SOFT TISSUE CELLS"

GENEVA, Dec. 8 -- INSTITUT STRAUMANN AG (Peter Merian-Weg 124052 Basel) filed a patent application (PCT/EP2025/064525) for "INJECTABLE COMPOSITIONS COMPRISING ENAMEL MATRIX DERIVATIVE (EMD) PROTEINS AND HUMAN SOFT TISSUE CELLS" on May 26, 2025. With publication no. WO/2025/247842, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DARD, Michel (c/o Institut Straumann AGPeter Merian-Weg 124052 Basel), WANGNERUD, Per (c/o Biora ABPer Albin Hanssons vag 41214 32 Malmo)

Abstract: The present invention relates to a pharmaceutica...